The payer, which isn’t named, represents 837,000 patients across Utah and Idaho, according to a news release. Its policy provides coverage for patients with symptomatic degenerative disc disease who are treated with the Prodisc L.
Centinel Spine’s Prodisc L is the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
